Thrombolytic drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. A new study (“Risk of Aneurysm ...

A new anti-thrombosis drug based on magnetite nanoparticles developed at ITMO University has been successfully tested on animals. Preclinical studies showed the drug's high efficacy and lack of side ...

Bayer has started proof-of-concept testing of a potential new therapy for patients with deep vein thrombosis (DVT) that works in a different way to current drugs. The German group has started a phase ...

Acute ischemic stroke accounts for about 87% of all stroke cases worldwide, necessitating swift action to restore blood flow and minimize neurological damage. Tenecteplase and Alteplase are key ...